Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
85.41%
Operating Margin
29.55%
Net Margin
34.25%

Efficiency Metrics

Revenue per Expense Ratio
1.50
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.4600000000

Balance Sheet Analysis

Current Ratio
10.31
Cash Ratio
10.31
Working Capital
$287.17M
Debt to Equity
2.63
Debt to Assets
46.44%
Equity Ratio
17.64%

Cash Flow Analysis

Operating Cash Flow Ratio
46.46%
Free Cash Flow Ratio
46.46%
CapEx to Revenue
0.00%
Dividends Paid
$175.98M
Stock Buybacks
$7.00K
Total Shareholder Returns
$175.99M
Cash Position Change
-1.19%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes

Detailed Growth Metrics

Core Performance

Revenue
19.50%
Net Income
132.41%
EPS
119.17%
Operating Income
127.41%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
15.47%
Operating Cash Flow
-70.30%
Free Cash Flow
-70.27%

Balance Sheet Health

Assets
18.22%
Debt
37.81%
Book Value per Share
-3.59%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
-18.13%
Shares Outstanding
-0.91%

Long Term Trends

3Y Revenue/Share
146.55%
5Y Revenue/Share
-31.06%
3Y Dividend/Share
35.77%
5Y Dividend/Share
-47.70%